首页 | 本学科首页   官方微博 | 高级检索  
     


Immunomodulatory Activity of Recombinant Ricin Toxin Binding Subunit B (RTB)
Authors:Wensen Liu  Na Xu  Hongyan Yuan  Songyan Li  Linna Liu  Zhaoyang Pu  Jiayu Wan  Huiwen Wang  Yaping Chang  Ruisheng Li
Affiliation:1.Institute of Military Veterinary, Academy of Military Medical Sciences, Zoonosis Prevention and Control Key Laboratory, Changchun 130122, China; E-Mails: (N.X.); (S.L.); (L.L.); (Z.P.); (J.W.);2.Department of Immunology, Norman Bethune College of Medical Science, Jilin University, Changchun 130021, China; E-Mails: (H.Y.); (H.W.);3.Dean’s Office, Jilin Medical College, Jilin 132013, China;4.Animal Laboratory Center, 302 Hospital of People’s Liberation Army, Beijing 100039, China
Abstract:Ricin toxin binding subunit B (RTB) is one of the subunits of the ricin protein. RTB has been used as adjuvant, but little is known about its mechanism. In this study, we found that RTB increased not only nitric oxide (NO) release, but also tumor necrosis factor (TNF)-α and interleukin (IL)-6 production in mouse macrophage cell line RAW264.7 cells. They subsequently exhibited enhanced ConA-induced T-cell and LPS-induced B-cell proliferative responses. We also examined the cytokines that were produced from splenocytes following in vitro RTB administration. Increased levels of IL-2, interferon (IFN)-γ and TNF-α were observed, while IL-4 and IL-5 were unaffected. These results demonstrate that recombinant RTB can act on the immune system and activate T-cells by introducing a Th1 immune response. Th1 cells might be the primary cellular target affected by RTB. Our results suggest that the recombinant RTB can promote the activation of macrophages and has a beneficial effect on immunomodulatory activity.
Keywords:RTB   macrophage   lymphocyte proliferation   Th1 cell   cytokine
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号